Goldman Sachs analyst Noah Poponak lowered the firm’s price target on Booz Allen (BAH) to $80 from $93 and keeps a Sell rating on the shares. Revenue declined in the quarter at an accelerated pace, and the company revised FY26 guidance for revenue down 7%, EBITDA down 10%, and EPS down 13%, the analyst tells investors in a research note. A U.S. government funding re-prioritization is impacting Booz Allen, while Goldman also continues to see risk to margins as the customer looks to shift more risk to companies via contract terms.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAH:
- BofA Double-Downgrades Booz Allen (BAH) after Weak Q2 Results
- Booz Allen Hamilton Earnings Call: Mixed Sentiment Amid Challenges
- Booz Allen price target lowered to $106 from $119 at Stifel
- Booz Allen price target lowered to $90 from $110 at Truist
- BofA double downgrades Booz Allen to Underperform on civil weakness
